Research Continues: Join the Discovery on Target Virtual Community

As the coronavirus situation further develops, the health and well-being of our community remains our top priority. We would never have dreamt our world would be facing such uncertain times. Our team has been working for months behind the scenes planning the 2020 event, monitoring and adapting to these new circumstances. We’re excited we can still support your scientific collaborations – now virtually – this fall.

Discovery on Target (DOT) is the industry’s preeminent event on novel drug targets and technologies for drug discovery professionals. DOT highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.

We aim to meet your research needs. Delegates can virtually visit numerous concurrent sessions and – with on-demand access to presentations – benefit even from those you can’t attend live. You can customize your experience further through focused short courses, interactive breakout discussions, and virtual networking options that help you engage with experts and solutions providers from the comfort of home.

What’s New in 2020?

Our 2020 program includes new topics on proteomics, small G proteins, disease modeling, preclinical oncology models and tools, CNS, gene and cell therapy, and biomarkers, plus lead and candidate selection for therapeutic proteins and modality selection for next-generation biotherapeutics to continue our growing coverage of biologics.

Your work is valuable and necessary. We’re here to help that research continue as we welcome you to our 18th annual, virtually enhanced event!